237 related articles for article (PubMed ID: 31117066)
1. Prognostic Value of Microscopic Hematuria after Induction of Remission in Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis.
Vandenbussche C; Bitton L; Bataille P; Glowacki F; Azar R; Hatron PY; Macnamara E; Gheerbrant JD; Cardon G; Hoffmann M; Auxenfants E; Gnemmi V; Quéméneur T
Am J Nephrol; 2019; 49(6):479-486. PubMed ID: 31117066
[TBL] [Abstract][Full Text] [Related]
2. The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated Vasculitis.
Rhee RL; Davis JC; Ding L; Fervenza FC; Hoffman GS; Kallenberg CGM; Langford CA; McCune WJ; Monach PA; Seo P; Spiera R; St Clair EW; Specks U; Stone JH; Merkel PA
Clin J Am Soc Nephrol; 2018 Feb; 13(2):251-257. PubMed ID: 29371340
[TBL] [Abstract][Full Text] [Related]
3. Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival.
Lin W; Shen C; Zhong Y; Ooi JD; Eggenhuizen P; Zhou YO; Luo H; Huang J; Chen JB; Wu T; Meng T; Xiao Z; Ao X; Peng W; Tang R; Yin H; Xiao X; Zhou Q; Xiao P
Front Immunol; 2021; 12():625672. PubMed ID: 33841408
[TBL] [Abstract][Full Text] [Related]
4. Proteinuria and hematuria after remission induction are associated with outcome in ANCA-associated vasculitis.
Benichou N; Charles P; Terrier B; Jones RB; Hiemstra T; Mouthon L; Bajema I; Berden A; Thervet E; Guillevin L; Jayne D; Karras A;
Kidney Int; 2023 Jun; 103(6):1144-1155. PubMed ID: 36940799
[TBL] [Abstract][Full Text] [Related]
5. Sequential Therapy for Remission Induction in Severe Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis.
Kant S; Habbach A; Gapud EJ; Manno RL; Gattu R; Seo P; Geetha D
Am J Nephrol; 2019; 50(5):386-391. PubMed ID: 31593967
[TBL] [Abstract][Full Text] [Related]
6. Clinico-pathological features and outcomes of patients with propylthiouracil-associated ANCA vasculitis with renal involvement.
Chen Y; Bao H; Liu Z; Zhang H; Zeng C; Liu Z; Hu W
J Nephrol; 2014 Apr; 27(2):159-64. PubMed ID: 24570072
[TBL] [Abstract][Full Text] [Related]
7. ANCA-associated glomerulonephritis in the very elderly.
Bomback AS; Appel GB; Radhakrishnan J; Shirazian S; Herlitz LC; Stokes B; D'Agati VD; Markowitz GS
Kidney Int; 2011 Apr; 79(7):757-64. PubMed ID: 21160463
[TBL] [Abstract][Full Text] [Related]
8. The predictive value of kidney biopsy in renal vasculitis: a multicenter cohort study.
Diaz-Crespo F; Villacorta J; Acevedo M; Cavero T; Guerrero C; García Díaz E; Orradre JL; Martinez MA; Praga M; Fernandez-Juarez G
Hum Pathol; 2016 Jun; 52():119-27. PubMed ID: 26980047
[TBL] [Abstract][Full Text] [Related]
9. Rituximab for treatment of severe renal disease in ANCA associated vasculitis.
Geetha D; Hruskova Z; Segelmark M; Hogan J; Morgan MD; Cavero T; Eriksson P; Seo P; Manno RL; Dale J; Harper L; Tesar V; Jayne DR
J Nephrol; 2016 Apr; 29(2):195-201. PubMed ID: 25986390
[TBL] [Abstract][Full Text] [Related]
10. Persistent hematuria in patients with antineutrophil cytoplasmic antibody-associated vasculitis during clinical remission: chronic glomerular lesion or low-grade active renal vasculitis?
Lv L; Chang DY; Li ZY; Chen M; Hu Z; Zhao MH
BMC Nephrol; 2017 Dec; 18(1):354. PubMed ID: 29207950
[TBL] [Abstract][Full Text] [Related]
11. ANCA renal risk score predicts outcome in the Manchester cohort.
Li AS; Saleh C; Denley H; Patel M; Brix SR
Kidney Int; 2019 Jul; 96(1):246-247. PubMed ID: 31229033
[No Abstract] [Full Text] [Related]
12. Effect of Disease Activity at Three and Six Months After Diagnosis on Long-Term Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Gopaluni S; Flossmann O; Little MA; O'Hara P; Bekker P; Jayne D;
Arthritis Rheumatol; 2019 May; 71(5):784-791. PubMed ID: 30418705
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors for Relapse of Antineutrophil Cytoplasmic Antibody-associated Vasculitis in Japan: A Nationwide, Prospective Cohort Study.
Hara A; Wada T; Sada KE; Amano K; Dobashi H; Harigai M; Takasaki Y; Yamada H; Hasegawa H; Hayashi T; Fujimoto S; Muso E; Kawakami T; Homma S; Yoshida M; Hirahashi J; Ogawa N; Ito S; Makino H; Arimura Y;
J Rheumatol; 2018 Apr; 45(4):521-528. PubMed ID: 29419469
[TBL] [Abstract][Full Text] [Related]
14. Clinical, serological and histological determinants of patient and renal outcome in ANCA-associated vasculitis with renal involvement: an analysis from a referral centre.
Crnogorac M; Horvatic I; Toric L; Galesic Ljubanovic D; Tisljar M; Galesic K
Int Urol Nephrol; 2017 Aug; 49(8):1419-1431. PubMed ID: 28646482
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and outcome of pauci-immune glomerulonephritis in African Americans.
Geetha D; Poulton CJ; Hu Y; Seo P; McGregor JA; Falk RJ; Hogan SL
Semin Arthritis Rheum; 2014 Jun; 43(6):778-83. PubMed ID: 24387818
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
Maritati F; Alberici F; Oliva E; Urban ML; Palmisano A; Santarsia F; Andrulli S; Pavone L; Pesci A; Grasselli C; Santi R; Tumiati B; Manenti L; Buzio C; Vaglio A
PLoS One; 2017; 12(10):e0185880. PubMed ID: 29016646
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody Glomerulonephritis.
Menez S; Hruskova Z; Scott J; Cormican S; Chen M; Salama AD; Alasfar S; Little MA; Safrankova H; Honsova E; Tesar V; Geetha D
Am J Nephrol; 2018; 48(6):465-471. PubMed ID: 30472700
[TBL] [Abstract][Full Text] [Related]
18. ANCA positive crescentic glomerulonephritis outcome in a Central East European cohort: a retrospective study.
Andreiana I; Stancu S; Avram A; Taran L; Mircescu G
BMC Nephrol; 2015 Jun; 16():90. PubMed ID: 26123651
[TBL] [Abstract][Full Text] [Related]
19. Clinical and pathological study on patients with primary antineutrophil cytoplasmic autoantibody-associated vasculitis with renal immune complex deposition.
Li X; Zhang W; Yu HJ; Pan XX; Shen PY; Ren H; Wang WM; Chen N
J Clin Rheumatol; 2015 Jan; 21(1):3-9. PubMed ID: 25539426
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Severe Kidney Disease.
Casal Moura M; Irazabal MV; Eirin A; Zand L; Sethi S; Borah BJ; Winters JL; Moriarty JP; Cartin-Ceba R; Berti A; Baqir M; Thompson GE; Makol A; Warrington KJ; Thao V; Specks U; Fervenza FC
J Am Soc Nephrol; 2020 Nov; 31(11):2688-2704. PubMed ID: 32826324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
